Cytokine-based human whole blood assay for the detection of antigen-reactive T cells-Reference-Cited by-同舟云学术

Cytokine-based human whole blood assay for the detection of antigen-reactive T cells

Published:1995-10 Issue:1 Volume:186 Page:37-46
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Petrovsky Nikolai,Harrison Leonard C.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. Catalyzed reporter deposition, a novel method of signal amplification;Bobrow;J. Immunol. Methods,1989

2. Correlation between in vitro cytokine production and clinical evolution of multiple sclerosis patients;Chofflon;Schweiz. Arch. Neurol. Psychiatr.,1991

3. Natural regulators of T-cell lymphokine production in vivo;Daynes;J. Immunother.,1992

4. Direct stimulation of cytokines (IL-1b, TNA-α, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation;De Groote;Cytokine,1992

5. Secondary immunization with a protein antigen (tetanus toxoid) in man;Donnenberg;Scand. J. Immunol.,1984

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III clinical study;2023-01-03

2. Evaluation of safety and immunogenicity of receptor-binding domain-based COVID-19 vaccine (Corbevax) to select the optimum formulation in open-label, multicentre, and randomised phase-1/2 and phase-2 clinical trials;eBioMedicine;2022-09

3. Toll-Like Receptor-Induced Immune Responses During Early Childhood and Their Associations With Clinical Outcomes Following Acute Illness Among Infants in Sub-Saharan Africa;Frontiers in Immunology;2022-02-03

4. A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease;Frontiers in Immunology;2021-05-19

5. Optimization of a nicotine degrading enzyme for potential use in treatment of nicotine addiction;BMC Biotechnology;2019-08-02